Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yantao He

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agentsBo Zhou, Yantao He, Xian Zhang, et al.
Free Radical Biology & Medicine|December 26, 2024
The protein tyrosine phosphatase Lyp/PTPN22 drives TNFα-induced priming of superoxide anions production by neutrophils and arthritisAnaïs Gardette, Viviana Marzaioli, Samia Bedouhene, et al.
Journal of Medicinal Chemistry|May 30, 2013
A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseasesYantao He, Sijiu Liu, Ambili Menon, et al.
Molecular Metabolism|July 9, 2022
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese micePatrick J Knerr, Stephanie A Mowery, Jonathan D Douros, et al.
Journal of Medicinal Chemistry|February 23, 2010
Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)Xian Zhang, Yantao He, Sijiu Liu, et al.
The Journal of Biological Chemistry|June 11, 2009
Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemiaWenjun Zhang, Rebecca J Chan, Hanying Chen, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 InhibitorsRongjun He, Zhi-Hong Yu, Ruo-Yu Zhang, et al.
Cellular and Molecular Life Sciences : CMLS|November 28, 2024
GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cellsNatália da Silva Lima, Alba Cabaleiro, Eva Novoa, et al.
Journal of Medicinal Chemistry|February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cellsStephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Blood|July 19, 2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KITRaghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agentsBo Zhou, Yantao He, Xian Zhang, et al.
Free Radical Biology & Medicine|December 26, 2024
The protein tyrosine phosphatase Lyp/PTPN22 drives TNFα-induced priming of superoxide anions production by neutrophils and arthritisAnaïs Gardette, Viviana Marzaioli, Samia Bedouhene, et al.
Journal of Medicinal Chemistry|May 30, 2013
A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseasesYantao He, Sijiu Liu, Ambili Menon, et al.
Molecular Metabolism|July 9, 2022
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese micePatrick J Knerr, Stephanie A Mowery, Jonathan D Douros, et al.
Journal of Medicinal Chemistry|February 23, 2010
Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)Xian Zhang, Yantao He, Sijiu Liu, et al.
The Journal of Biological Chemistry|June 11, 2009
Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemiaWenjun Zhang, Rebecca J Chan, Hanying Chen, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 InhibitorsRongjun He, Zhi-Hong Yu, Ruo-Yu Zhang, et al.
Cellular and Molecular Life Sciences : CMLS|November 28, 2024
GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cellsNatália da Silva Lima, Alba Cabaleiro, Eva Novoa, et al.
Journal of Medicinal Chemistry|February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cellsStephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Blood|July 19, 2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KITRaghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, et al.
Pageof 4